Attention-deficit hyperactivity disorders. Attention-deficit hyperactivity disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18–40 years and Provision of written informed consent Willingness to attend sessions regularly Absence of active psychotic disorders or neurological conditions ADHD eligibility was established via clinical interview and DSM-5-TR criteria (American Psychiatric Association, 2022) and a Barkley-based diagnostic procedure, such that the presence of =3 symptoms in either the inattention domain or the hyperactivity–impulsivity domain, and =5 symptoms on the total ADHD index will consider clinically meaningful.
Exclusion criteria
Exclusion criteria: Missing more than two treatment sessions Initiation of, or substantial change in, concurrent pharmacotherapy or psychotherapy during the study period; Emergence of acute clinical conditions (e.g., manic episode or psychotic symptoms) that interfered with continuing the intervention Withdrawal from the study or failure to complete post-test or follow-up assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Planning. Timepoint: Pre-test, post-test, immediately after treatment, follow-up 2 months after treatment. Method of measurement: Final score on the Tower of London benchmark test.;Sustained attention. Timepoint: Pre-test, post-test, follow-up. Method of measurement: Omission errors in CPT.;Wisconsin Card Sorting. Timepoint: Pre-test, post-test, follow-up. Method of measurement: Number of categories completed on the Wisconsin Card Sorting Test (WCST). | — |
Secondary
| Measure | Time frame |
|---|---|
| NO. Timepoint: NO. Method of measurement: NO. | — |
Countries
Iran (Islamic Republic of)
Contacts
Persian Gulf University